chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Residual numbness in my cheeks; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Residual numbness in my cheeks) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Residual numbness in my cheeks). At the time of the report, HYPOAESTHESIA (Residual numbness in my cheeks) outcome was unknown.            No concomitant medication were provided by reporter. No treatment details were provided by reporter.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Influenza like illness, Myalgia, Pyrexia
Clinical narrative: Felt like I had the flu; Fever/ up to 100.9/ febrile for close to 24 hours; Chills; Body aches; This spontaneous case was reported by a pharmacist and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like I had the flu), PYREXIA (Fever/ up to 100.9/ febrile for close to 24 hours), CHILLS (Chills) and MYALGIA (Body aches) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination.     The patient's past medical history included Exposure to mold (has previously been exposed to black mold). Concurrent medical conditions included Type 2 diabetes mellitus and Asthma.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like I had the flu), PYREXIA (Fever/ up to 100.9/ febrile for close to 24 hours), CHILLS (Chills) and MYALGIA (Body aches). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1500 mg every eight hours. In February 2021, INFLUENZA LIKE ILLNESS (Felt like I had the flu), PYREXIA (Fever/ up to 100.9/ febrile for close to 24 hours), CHILLS (Chills) and MYALGIA (Body aches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Body temperature: up to 100.9°f. (High) a fever of 100.9°F..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The Patient is on Type 2 Diabetic medication.   This case was linked to MOD-2021-301965, MOD-2021-302003 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Depressed mood, Emotional distress, Erythema, Feeling hot
Clinical narrative: Patient was upset /very upset about the uncertainty of her condition; Rash like a big spot; Swelling on lymph nodes; Arm pit became tender; Mental state was distressed; Skin was peeling off; Sensation of a scar; Arm pit became red; Arm pit became hot and irritated; COVID19 vaccine activated the cancer cells; This spontaneous case was reported by a consumer and describes the occurrence of EMOTIONAL DISTRESS (Mental state was distressed), SKIN EXFOLIATION (Skin was peeling off), SCAR PAIN (Sensation of a scar), ERYTHEMA (Arm pit became red) and FEELING HOT (Arm pit became hot and irritated) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A and 02XC21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Mastectomy bilateral in 2013 and Lymph node dissection (2 lymph nodes which were benign.). Concurrent medical conditions included Breast cancer NOS recurrent (affected on 1% of patients who had a bilateral mastectomy) since March 2015.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Aug-2021, the patient experienced EMOTIONAL DISTRESS (Mental state was distressed), SKIN EXFOLIATION (Skin was peeling off), SCAR PAIN (Sensation of a scar), ERYTHEMA (Arm pit became red), FEELING HOT (Arm pit became hot and irritated), VACCINATION COMPLICATION (COVID19 vaccine activated the cancer cells), RASH (Rash like a big spot), LYMPHADENOPATHY (Swelling on lymph nodes) and AXILLARY PAIN (Arm pit became tender). On an unknown date, the patient experienced DEPRESSED MOOD (Patient was upset /very upset about the uncertainty of her condition). At the time of the report, EMOTIONAL DISTRESS (Mental state was distressed), SKIN EXFOLIATION (Skin was peeling off), SCAR PAIN (Sensation of a scar), ERYTHEMA (Arm pit became red), FEELING HOT (Arm pit became hot and irritated), VACCINATION COMPLICATION (COVID19 vaccine activated the cancer cells), RASH (Rash like a big spot), LYMPHADENOPATHY (Swelling on lymph nodes) and AXILLARY PAIN (Arm pit became tender) had not resolved and DEPRESSED MOOD (Patient was upset /very upset about the uncertainty of her condition) outcome was unknown.            Patient stated took concomitant medications of breast cancer medication and since 2016 and took ultrasound test.  Patient suggested the COVID19 vaccine activated the cancer cells, that she was on remission and that she wasn't sure that the vaccine was safe for cancer patients and that she didn't want her lymph nodes to be bothered.  No treatment medications were provided by reporter.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Rash, Scar pain, Skin exfoliation, Vaccination complication
Clinical narrative: Patient was upset /very upset about the uncertainty of her condition; Rash like a big spot; Swelling on lymph nodes; Arm pit became tender; Mental state was distressed; Skin was peeling off; Sensation of a scar; Arm pit became red; Arm pit became hot and irritated; COVID19 vaccine activated the cancer cells; This spontaneous case was reported by a consumer and describes the occurrence of EMOTIONAL DISTRESS (Mental state was distressed), SKIN EXFOLIATION (Skin was peeling off), SCAR PAIN (Sensation of a scar), ERYTHEMA (Arm pit became red) and FEELING HOT (Arm pit became hot and irritated) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A and 02XC21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Mastectomy bilateral in 2013 and Lymph node dissection (2 lymph nodes which were benign.). Concurrent medical conditions included Breast cancer NOS recurrent (affected on 1% of patients who had a bilateral mastectomy) since March 2015.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Aug-2021, the patient experienced EMOTIONAL DISTRESS (Mental state was distressed), SKIN EXFOLIATION (Skin was peeling off), SCAR PAIN (Sensation of a scar), ERYTHEMA (Arm pit became red), FEELING HOT (Arm pit became hot and irritated), VACCINATION COMPLICATION (COVID19 vaccine activated the cancer cells), RASH (Rash like a big spot), LYMPHADENOPATHY (Swelling on lymph nodes) and AXILLARY PAIN (Arm pit became tender). On an unknown date, the patient experienced DEPRESSED MOOD (Patient was upset /very upset about the uncertainty of her condition). At the time of the report, EMOTIONAL DISTRESS (Mental state was distressed), SKIN EXFOLIATION (Skin was peeling off), SCAR PAIN (Sensation of a scar), ERYTHEMA (Arm pit became red), FEELING HOT (Arm pit became hot and irritated), VACCINATION COMPLICATION (COVID19 vaccine activated the cancer cells), RASH (Rash like a big spot), LYMPHADENOPATHY (Swelling on lymph nodes) and AXILLARY PAIN (Arm pit became tender) had not resolved and DEPRESSED MOOD (Patient was upset /very upset about the uncertainty of her condition) outcome was unknown.            Patient stated took concomitant medications of breast cancer medication and since 2016 and took ultrasound test.  Patient suggested the COVID19 vaccine activated the cancer cells, that she was on remission and that she wasn't sure that the vaccine was safe for cancer patients and that she didn't want her lymph nodes to be bothered.  No treatment medications were provided by reporter.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Are is sre at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Are is sre at injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis and Prostate cancer.   In January 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Are is sre at injection site). At the time of the report, MYALGIA (Are is sre at injection site) outcome was unknown.      No Concomitant medication information was reported. No treatment medications were provided.   This case was linked to MOD-2021-301904 (Patient Link).
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The vial was punctured on 26-AUG-2021 at 1:15PM. The dose was given to the patient on 27-AUG-2021 at 11:50AM; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vial was punctured on 26-AUG-2021 at 1:15PM. The dose was given to the patient on 27-AUG-2021 at 11:50AM) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A and 021C21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Intellectual disability, Schizophrenia and Vitamin D deficiency.   On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Aug-2021 at 11:50 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Aug-2021 at 11:50 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (The vial was punctured on 26-AUG-2021 at 1:15PM. The dose was given to the patient on 27-AUG-2021 at 11:50AM). On 27-Aug-2021 at 11:50 AM, EXPIRED PRODUCT ADMINISTERED (The vial was punctured on 26-AUG-2021 at 1:15PM. The dose was given to the patient on 27-AUG-2021 at 11:50AM) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment information was not reported.  Reporter also states that The patient did not report any other adverse reactions after the first or the second dose of Moderna Covid-19 vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 03-Sep-2021: Follow-up information included patient details, past medical history and vaccine dose details.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Really weird adverse reaction/weird side effect; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Really weird adverse reaction/weird side effect) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Really weird adverse reaction/weird side effect). At the time of the report, VACCINATION COMPLICATION (Really weird adverse reaction/weird side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported.  Treatment medication were not reported.  Patient got the Moderna vaccine Saturday morning and was having a really weird adverse reaction, a weird side effect.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness on the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness on the arm) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     The patient's past medical history included Eczema since an unknown date. Concomitant products included DUPILUMAB (DUPIXENT) for Eczema.  On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced PAIN IN EXTREMITY (Soreness on the arm). At the time of the report, PAIN IN EXTREMITY (Soreness on the arm) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment information was not  provided.   This case was linked to MOD-2021-302087 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Myalgia, Pyrexia, Suspected COVID-19
Clinical narrative: Cough; Spiked proteins; Body aches; A low grade fever; This spontaneous case was reported by an other health care professional and describes the occurrence of COUGH (Cough), SUSPECTED COVID-19 (Spiked proteins), MYALGIA (Body aches) and PYREXIA (A low grade fever) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), CITALOPRAM HYDROBROMIDE (CELEXA [CITALOPRAM HYDROBROMIDE]), WARFARIN SODIUM (COUMADIN), OMEPRAZOLE and LEVOTHYROXINE for an unknown indication.    On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (Cough), SUSPECTED COVID-19 (Spiked proteins), MYALGIA (Body aches) and PYREXIA (A low grade fever). The patient was treated with ACYCLOVIR [ACICLOVIR] for Shingles, at an unspecified dose and frequency. At the time of the report, COUGH (Cough) and SUSPECTED COVID-19 (Spiked proteins) outcome was unknown and MYALGIA (Body aches) and PYREXIA (A low grade fever) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-301941 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: got tired after the first vaccine; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (got tired after the first vaccine) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis. Concomitant products included OCRELIZUMAB (OCREVUS) for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (got tired after the first vaccine). At the time of the report, FATIGUE (got tired after the first vaccine) outcome was unknown.            No treatment details were provided by reporter.  Her blood test from 20-Aug-2021 shows that she has 0.4 non-detectable SARS-Co-V-2 antibodies .   This case was linked to MOD-2021-302110.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Fear, Feeling abnormal, Loss of personal independence in daily activities, Nausea
Clinical narrative: miserable/I was pretty much incapacitated for about 28 hours; excruciating pain; incapacitated for about 28 hours/had to help her get up just to use the bathroom/could not get up off the couch; Scared to get the third shot; did vomit; very nauseous; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (miserable/I was pretty much incapacitated for about 28 hours), PAIN (excruciating pain), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (incapacitated for about 28 hours/had to help her get up just to use the bathroom/could not get up off the couch), FEAR (Scared to get the third shot) and VOMITING (did vomit) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Multiple sclerosis. Concomitant products included OCRELIZUMAB (OCREVUS) for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced FEELING ABNORMAL (miserable/I was pretty much incapacitated for about 28 hours), PAIN (excruciating pain), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (incapacitated for about 28 hours/had to help her get up just to use the bathroom/could not get up off the couch), FEAR (Scared to get the third shot), VOMITING (did vomit) and NAUSEA (very nauseous). At the time of the report, FEELING ABNORMAL (miserable/I was pretty much incapacitated for about 28 hours), PAIN (excruciating pain), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (incapacitated for about 28 hours/had to help her get up just to use the bathroom/could not get up off the couch), FEAR (Scared to get the third shot), VOMITING (did vomit) and NAUSEA (very nauseous) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Aug-2021, Blood test: 0.4 (Inconclusive) 0.4 non-detectable SARS-Co-V-2 antibodies IgM present..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not reported.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-302102 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vomiting
Clinical narrative: miserable/I was pretty much incapacitated for about 28 hours; excruciating pain; incapacitated for about 28 hours/had to help her get up just to use the bathroom/could not get up off the couch; Scared to get the third shot; did vomit; very nauseous; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (miserable/I was pretty much incapacitated for about 28 hours), PAIN (excruciating pain), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (incapacitated for about 28 hours/had to help her get up just to use the bathroom/could not get up off the couch), FEAR (Scared to get the third shot) and VOMITING (did vomit) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Multiple sclerosis. Concomitant products included OCRELIZUMAB (OCREVUS) for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced FEELING ABNORMAL (miserable/I was pretty much incapacitated for about 28 hours), PAIN (excruciating pain), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (incapacitated for about 28 hours/had to help her get up just to use the bathroom/could not get up off the couch), FEAR (Scared to get the third shot), VOMITING (did vomit) and NAUSEA (very nauseous). At the time of the report, FEELING ABNORMAL (miserable/I was pretty much incapacitated for about 28 hours), PAIN (excruciating pain), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (incapacitated for about 28 hours/had to help her get up just to use the bathroom/could not get up off the couch), FEAR (Scared to get the third shot), VOMITING (did vomit) and NAUSEA (very nauseous) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Aug-2021, Blood test: 0.4 (Inconclusive) 0.4 non-detectable SARS-Co-V-2 antibodies IgM present..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not reported.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-302102 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Got sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Got sick) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Got sick). At the time of the report, ILLNESS (Got sick) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Lethargy
Clinical narrative: Lethargy after receiving Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargy after receiving Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LETHARGY (Lethargy after receiving Moderna vaccine). At the time of the report, LETHARGY (Lethargy after receiving Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 01-Sep-2021: Follow-up received contains no new information.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Arm was itching; Arm was hard; Arm was swollen; Arm became red / Sunday her arm was much redder; She received her 2nd dose 28Jan2021 (lot was accidentally deleted) and her 3rd dose 27Aug2021 Lot 088D21A; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She received her 2nd dose 28Jan2021 (lot was accidentally deleted) and her 3rd dose 27Aug2021 Lot 088D21A), VACCINATION SITE PRURITUS (Arm was itching), VACCINATION SITE INDURATION (Arm was hard), VACCINATION SITE ERYTHEMA (Arm became red / Sunday her arm was much redder) and VACCINATION SITE SWELLING (Arm was swollen) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She received her 2nd dose 28Jan2021 (lot was accidentally deleted) and her 3rd dose 27Aug2021 Lot 088D21A). On 27-Aug-2021, the patient experienced VACCINATION SITE ERYTHEMA (Arm became red / Sunday her arm was much redder). On 29-Aug-2021, the patient experienced VACCINATION SITE INDURATION (Arm was hard) and VACCINATION SITE SWELLING (Arm was swollen). On 30-Aug-2021, the patient experienced VACCINATION SITE PRURITUS (Arm was itching). On 27-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She received her 2nd dose 28Jan2021 (lot was accidentally deleted) and her 3rd dose 27Aug2021 Lot 088D21A) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Arm was itching), VACCINATION SITE INDURATION (Arm was hard), VACCINATION SITE ERYTHEMA (Arm became red / Sunday her arm was much redder) and VACCINATION SITE SWELLING (Arm was swollen) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed the second shot 48 days post first vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed the second shot 48 days post first vaccine) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Aug-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed the second shot 48 days post first vaccine). On 30-Aug-2021, PRODUCT DOSE OMISSION ISSUE (Missed the second shot 48 days post first vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment information was reported.  The patient was yet to received second dose.
Sex: U
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Chest pain  after taking Moderna; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain  after taking Moderna) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pain  after taking Moderna). At the time of the report, CHEST PAIN (Chest pain  after taking Moderna) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided by the reporter. No Treatment information was reported.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine given to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine given to patient) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine given to patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine given to patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Relevant concomitant medications were not reported by reporter. Treatment information was not provided by reporter.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Got his second dose few months after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got his second dose few months after the first dose) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21B and 058E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got his second dose few months after the first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got his second dose few months after the first dose) had resolved.            No concomitant product use was provided by the reporter.   No treatment medications were reported.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Erythema, Joint swelling
Clinical narrative: swelling in my hands /swelling in my feet; swelling in both knees; since the vaccine my joints have been aching; dizziness; my arms and chest turned itchy; my arms and chest turned bright red; nausea; chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 30-Aug-2021 and was forwarded to Moderna on 30-Aug-2021.    This spontaneous case was reported by an other health care professional and describes the occurrence of DIZZINESS (dizziness), PRURITUS (my arms and chest turned itchy), ERYTHEMA (my arms and chest turned bright red), SWELLING (swelling in my hands /swelling in my feet) and JOINT SWELLING (swelling in both knees) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DIPHENHYDRAMINE, NAPROXEN and PREDNISONE for an unknown indication.    On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Aug-2021, the patient experienced DIZZINESS (dizziness), PRURITUS (my arms and chest turned itchy), ERYTHEMA (my arms and chest turned bright red), NAUSEA (nausea) and CHILLS (chills). On an unknown date, the patient experienced SWELLING (swelling in my hands /swelling in my feet), JOINT SWELLING (swelling in both knees) and ARTHRALGIA (since the vaccine my joints have been aching). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form and PARACETAMOL (TYLENOL) for Joint pain, at a dose of 1 dosage form. At the time of the report, DIZZINESS (dizziness), PRURITUS (my arms and chest turned itchy), ERYTHEMA (my arms and chest turned bright red), SWELLING (swelling in my hands /swelling in my feet), JOINT SWELLING (swelling in both knees), NAUSEA (nausea), CHILLS (chills) and ARTHRALGIA (since the vaccine my joints have been aching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pruritus, Swelling
Clinical narrative: swelling in my hands /swelling in my feet; swelling in both knees; since the vaccine my joints have been aching; dizziness; my arms and chest turned itchy; my arms and chest turned bright red; nausea; chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 30-Aug-2021 and was forwarded to Moderna on 30-Aug-2021.    This spontaneous case was reported by an other health care professional and describes the occurrence of DIZZINESS (dizziness), PRURITUS (my arms and chest turned itchy), ERYTHEMA (my arms and chest turned bright red), SWELLING (swelling in my hands /swelling in my feet) and JOINT SWELLING (swelling in both knees) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DIPHENHYDRAMINE, NAPROXEN and PREDNISONE for an unknown indication.    On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Aug-2021, the patient experienced DIZZINESS (dizziness), PRURITUS (my arms and chest turned itchy), ERYTHEMA (my arms and chest turned bright red), NAUSEA (nausea) and CHILLS (chills). On an unknown date, the patient experienced SWELLING (swelling in my hands /swelling in my feet), JOINT SWELLING (swelling in both knees) and ARTHRALGIA (since the vaccine my joints have been aching). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form and PARACETAMOL (TYLENOL) for Joint pain, at a dose of 1 dosage form. At the time of the report, DIZZINESS (dizziness), PRURITUS (my arms and chest turned itchy), ERYTHEMA (my arms and chest turned bright red), SWELLING (swelling in my hands /swelling in my feet), JOINT SWELLING (swelling in both knees), NAUSEA (nausea), CHILLS (chills) and ARTHRALGIA (since the vaccine my joints have been aching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: severe chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (severe chills) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHILLS (severe chills). At the time of the report, CHILLS (severe chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.   This case was linked to MOD-2021-302223 (Patient Link).
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Feeling abnormal, Feeling cold, Headache, Hyperhidrosis
Clinical narrative: 2nd dose, feel bad; 2nd dose, very short of breath; 2nd dose could not move arm; 2nd dose sweats; 2nd dose cold; 2nd dose, do not feel good at all; 2nd dose, feel like throwing up; 2nd dose, bad headache/terrible headache; 2nd dose, arm sore right after shot; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (2nd dose, feel bad), DYSPNOEA (2nd dose, very short of breath), VACCINATION SITE MOVEMENT IMPAIRMENT (2nd dose could not move arm), HYPERHIDROSIS (2nd dose sweats) and FEELING COLD (2nd dose cold) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (2nd dose, feel bad), DYSPNOEA (2nd dose, very short of breath), VACCINATION SITE MOVEMENT IMPAIRMENT (2nd dose could not move arm), HYPERHIDROSIS (2nd dose sweats), FEELING COLD (2nd dose cold), VACCINATION COMPLICATION (2nd dose, do not feel good at all), NAUSEA (2nd dose, feel like throwing up), HEADACHE (2nd dose, bad headache/terrible headache) and PAIN IN EXTREMITY (2nd dose, arm sore right after shot). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Headache, at a dose of 2 tablets,every 4hrs. At the time of the report, FEELING ABNORMAL (2nd dose, feel bad), DYSPNOEA (2nd dose, very short of breath), VACCINATION SITE MOVEMENT IMPAIRMENT (2nd dose could not move arm), HYPERHIDROSIS (2nd dose sweats), FEELING COLD (2nd dose cold), VACCINATION COMPLICATION (2nd dose, do not feel good at all), NAUSEA (2nd dose, feel like throwing up) and PAIN IN EXTREMITY (2nd dose, arm sore right after shot) outcome was unknown and HEADACHE (2nd dose, bad headache/terrible headache) had not resolved.            Concomitant product use was not provided by the reporter.  Patient took 2 tablets of Advil every 4 hours, and the headache still didn't  go away.   This case was linked to MOD-2021-302196 (Patient Link).
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Vaccination complication, Vaccination site movement impairment
Clinical narrative: 2nd dose, feel bad; 2nd dose, very short of breath; 2nd dose could not move arm; 2nd dose sweats; 2nd dose cold; 2nd dose, do not feel good at all; 2nd dose, feel like throwing up; 2nd dose, bad headache/terrible headache; 2nd dose, arm sore right after shot; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (2nd dose, feel bad), DYSPNOEA (2nd dose, very short of breath), VACCINATION SITE MOVEMENT IMPAIRMENT (2nd dose could not move arm), HYPERHIDROSIS (2nd dose sweats) and FEELING COLD (2nd dose cold) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (2nd dose, feel bad), DYSPNOEA (2nd dose, very short of breath), VACCINATION SITE MOVEMENT IMPAIRMENT (2nd dose could not move arm), HYPERHIDROSIS (2nd dose sweats), FEELING COLD (2nd dose cold), VACCINATION COMPLICATION (2nd dose, do not feel good at all), NAUSEA (2nd dose, feel like throwing up), HEADACHE (2nd dose, bad headache/terrible headache) and PAIN IN EXTREMITY (2nd dose, arm sore right after shot). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Headache, at a dose of 2 tablets,every 4hrs. At the time of the report, FEELING ABNORMAL (2nd dose, feel bad), DYSPNOEA (2nd dose, very short of breath), VACCINATION SITE MOVEMENT IMPAIRMENT (2nd dose could not move arm), HYPERHIDROSIS (2nd dose sweats), FEELING COLD (2nd dose cold), VACCINATION COMPLICATION (2nd dose, do not feel good at all), NAUSEA (2nd dose, feel like throwing up) and PAIN IN EXTREMITY (2nd dose, arm sore right after shot) outcome was unknown and HEADACHE (2nd dose, bad headache/terrible headache) had not resolved.            Concomitant product use was not provided by the reporter.  Patient took 2 tablets of Advil every 4 hours, and the headache still didn't  go away.   This case was linked to MOD-2021-302196 (Patient Link).
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: First dose on 1-Jan-2021 and second dose on 19-Feb-2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 1-Jan-2021 and second dose on 19-Feb-2021) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Scoliosis, Neurological disorder NOS, Anemia, Dystonia, Allergy to chemicals, Allergy to antibiotic, Drug allergy (Allergy to most oral antifungals, muscle relaxant: Baclofen.) and Drug allergy (Baclofen muscle relaxant).   On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Aug-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On 19-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 1-Jan-2021 and second dose on 19-Feb-2021). On 19-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 1-Jan-2021 and second dose on 19-Feb-2021) had resolved.            Patient stated that she has autoimmune disease but its not official diagnosis.   No concomitant medications were reported.  Treatment information was not provided.   This case was linked to MOD-2021-302183 (Patient Link).
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dyskinesia, Headache, Illness
Clinical narrative: soreness in joints; severely sick; could not move and it  took 2 days to get out of her bed; very weird, different  and severe than normal flu symptoms; Chills; Fever with 100.9F; soreness in whole body- including joints, muscle.; weird headache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (severely sick), DYSKINESIA (could not move and it  took 2 days to get out of her bed), INFLUENZA LIKE ILLNESS (very weird, different  and severe than normal flu symptoms), CHILLS (Chills) and PYREXIA (Fever with 100.9F) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Aug-2021, the patient experienced ILLNESS (severely sick), DYSKINESIA (could not move and it  took 2 days to get out of her bed), INFLUENZA LIKE ILLNESS (very weird, different  and severe than normal flu symptoms), CHILLS (Chills), PYREXIA (Fever with 100.9F), MYALGIA (soreness in whole body- including joints, muscle.) and HEADACHE (weird headache). On an unknown date, the patient experienced ARTHRALGIA (soreness in joints). At the time of the report, ILLNESS (severely sick), DYSKINESIA (could not move and it  took 2 days to get out of her bed), INFLUENZA LIKE ILLNESS (very weird, different  and severe than normal flu symptoms), CHILLS (Chills), PYREXIA (Fever with 100.9F), MYALGIA (soreness in whole body- including joints, muscle.), HEADACHE (weird headache) and ARTHRALGIA (soreness in joints) was resolving.            The patient was feeling better on 29-Aug-2021. No Concomitant medications were provided. No treatment medications were provided.    This case was linked to MOD-2021-302184 (Patient Link).
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Myalgia, Pyrexia
Clinical narrative: soreness in joints; severely sick; could not move and it  took 2 days to get out of her bed; very weird, different  and severe than normal flu symptoms; Chills; Fever with 100.9F; soreness in whole body- including joints, muscle.; weird headache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (severely sick), DYSKINESIA (could not move and it  took 2 days to get out of her bed), INFLUENZA LIKE ILLNESS (very weird, different  and severe than normal flu symptoms), CHILLS (Chills) and PYREXIA (Fever with 100.9F) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Aug-2021, the patient experienced ILLNESS (severely sick), DYSKINESIA (could not move and it  took 2 days to get out of her bed), INFLUENZA LIKE ILLNESS (very weird, different  and severe than normal flu symptoms), CHILLS (Chills), PYREXIA (Fever with 100.9F), MYALGIA (soreness in whole body- including joints, muscle.) and HEADACHE (weird headache). On an unknown date, the patient experienced ARTHRALGIA (soreness in joints). At the time of the report, ILLNESS (severely sick), DYSKINESIA (could not move and it  took 2 days to get out of her bed), INFLUENZA LIKE ILLNESS (very weird, different  and severe than normal flu symptoms), CHILLS (Chills), PYREXIA (Fever with 100.9F), MYALGIA (soreness in whole body- including joints, muscle.), HEADACHE (weird headache) and ARTHRALGIA (soreness in joints) was resolving.            The patient was feeling better on 29-Aug-2021. No Concomitant medications were provided. No treatment medications were provided.    This case was linked to MOD-2021-302184 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In August 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm). At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was provided.  No Treatment medications was provided.   Reporter did not allow further contact